COMMUNIQUÉS West-GlobeNewswire

-
Allscripts to present at the Citi 2018 Global Healthcare Conference
04/12/2018 - 18:15 -
Agility Health Subsidiaries File Notice of Intention to Make a Proposal Under the Bankruptcy and Insolvency Act (Canada)
04/12/2018 - 18:04 -
VALNEVA to Conduct Investor and Partnering Meetings During the 37th Annual J.P. Morgan Healthcare Conference
04/12/2018 - 17:51 -
VALNEVA rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference
04/12/2018 - 17:51 -
Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018
04/12/2018 - 17:15 -
CAPS® Expands National Footprint, Opens New 503B Compounding Outsourcing Facility in Phoenix
04/12/2018 - 16:57 -
Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company
04/12/2018 - 16:49 -
The Alliance for Regenerative Medicine Announces 2019 Cell & Gene Therapies State of the Industry Briefing
04/12/2018 - 16:46 -
Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company
04/12/2018 - 16:19 -
Precipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other Investors
04/12/2018 - 15:15 -
Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)
04/12/2018 - 15:15 -
Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock
04/12/2018 - 15:14 -
Admera Health Adds Clinical Genomics Expert, Dr. Ruben Bonilla-Guerrero, to Management Team
04/12/2018 - 15:13 -
New Proximity Systems Open-Arm Cabinet Meets Space Constraints of Shrinking Patient Rooms
04/12/2018 - 15:00 -
Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma
04/12/2018 - 14:30 -
Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
04/12/2018 - 14:30 -
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/12/2018 - 14:30 -
PSIQ Grants Exclusive Distribution Rights for Mexico and Argentina With First Year Minimum Guarantee of $500,000 and 20% Growth Per Year Thereafter
04/12/2018 - 14:30 -
XBiotech annonce la réussite de l'audit BPF
04/12/2018 - 14:18
Pages